(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 5.42% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 20.95%.
Innospec's revenue in 2026 is $1,842,100,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $47,833,493,274, with the lowest IOSP revenue forecast at $44,138,836,224, and the highest IOSP revenue forecast at $50,666,063,679.
In 2027, IOSP is forecast to generate $50,666,063,679 in revenue, with the lowest revenue forecast at $46,478,785,689 and the highest revenue forecast at $53,966,623,977.